{"nct_id":"NCT06463665","title":"Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-09-26","start_date_type":"ACTUAL","primary_completion_date":"2027-02","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GNLX"]}